Literature DB >> 18391176

Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies.

H Criss Hartzell1, Zhiqiang Qu, Kuai Yu, Qinghuan Xiao, Li-Ting Chien.   

Abstract

This article reviews the current state of knowledge about the bestrophins, a newly identified family of proteins that can function both as Cl(-) channels and as regulators of voltage-gated Ca(2+) channels. The founding member, human bestrophin-1 (hBest1), was identified as the gene responsible for a dominantly inherited, juvenile-onset form of macular degeneration called Best vitelliform macular dystrophy. Mutations in hBest1 have also been associated with a small fraction of adult-onset macular dystrophies. It is proposed that dysfunction of bestrophin results in abnormal fluid and ion transport by the retinal pigment epithelium, resulting in a weakened interface between the retinal pigment epithelium and photoreceptors. There is compelling evidence that bestrophins are Cl(-) channels, but bestrophins remain enigmatic because it is not clear that the Cl(-) channel function can explain Best disease. In addition to functioning as a Cl(-) channel, hBest1 also is able to regulate voltage-gated Ca(2+) channels. Some bestrophins are activated by increases in intracellular Ca(2+) concentration, but whether bestrophins are the molecular counterpart of Ca(2+)-activated Cl(-) channels remains in doubt. Bestrophins are also regulated by cell volume and may be a member of the volume-regulated anion channel family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391176     DOI: 10.1152/physrev.00022.2007

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  153 in total

1.  SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium.

Authors:  Tomohiro Masuda; Noriko Esumi
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

Review 2.  International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels.

Authors:  Fen Huang; Xiuming Wong; Lily Y Jan
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

3.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 4.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

5.  Water cotransport in pigmented epithelial cells.

Authors:  Richard Naftalin
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

Review 6.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

Review 7.  Control of outflow resistance by soluble adenylyl cyclase.

Authors:  Yong Suk Lee; Alan D Marmorstein
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-09       Impact factor: 2.671

8.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

9.  Bestrophin expression and function in the human pancreatic duct cell line, CFPAC-1.

Authors:  Laura L Marsey; John P Winpenny
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 10.  BEST1: the Best Target for Gene and Cell Therapies.

Authors:  Tingting Yang; Sally Justus; Yao Li; Stephen H Tsang
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.